返回 Agenda
Session 1: Keynote Address
Session Chair(s)
Jacqueline A. Corrigan-Curay, JD, MD
Principal Deputy Center Director, Center for Drug Evaluation and Research (CDER)
FDA, United States
Session 1: Keynote Address
Hilton Arlington Towers
2022 年 09 月 20 日 7:00 上午 - 2022 年 09 月 21 日 3:00 下午
950 N Stafford St., Arlington, VA 22203-1813, USA
Biosimilars Conference
Convening Professionals in Biosimilar Development to Discuss the Challenges of Today and the Possibilities of Tomorrow